itolizumab
mAbexperimental
Itolizumab is a 'first in class' humanized IgG1 monoclonal antibody developed by Biocon and the Center of Molecular Immunology (CIM), Havana. — Wikipedia
Clinical trial activity
10 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
5
Phase 3
2
Phase 4
0
Earliest trial started Jun 20, 2019 (NCT04007198)
Timeline
Indications
Mechanism of action
- T-cell differentiation antigen CD6INHIBITOR
T-cell differentiation antigen CD6 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaItolizumab ↗
- ChEMBLCHEMBL1743033 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07105852 | Phase 2 | Jul 3, 2025 | Zhejiang University |
| NCT05978544 | Phase 1 | Dec 31, 2023 | Biotech Pharmaceutical Co., Ltd., Chinese Academy of Medical Sciences |
| NCT05986162 | Phase 1 | Dec 30, 2023 | Biotech Pharmaceutical Co., Ltd., Chinese Academy of Medical Sciences |
| NCT05823675 | Phase 1 | May 19, 2023 | Biotech Pharmaceutical Co., Ltd., Chinese Academy of Medical Sciences |
| NCT05263999 | Phase 3 | Apr 29, 2022 | Biocon Limited, Equillium |
| NCT04605926 | Phase 3 | Nov 30, 2020 | Biocon Limited, Equillium |
| NCT04475588 | Phase 2 | May 1, 2020 | Biocon Limited |
| NCT04128579 | Phase 1 | Oct 1, 2019 | Biocon Limited, Equillium, University of California, San Diego |
| NCT03763318 | Phase 1/Phase 2 (Phase 2) | Jun 30, 2019 | Biocon Limited, Equillium |
| NCT04007198 | Phase 1 | Jun 20, 2019 | Biocon Limited, Equillium, Melbourne Health |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biocon Limited | For profit | 6 | 1 | 3 | 2019 |
| Equillium | For profit | 5 | 5 | 3 | 2019 |
| Biotech Pharmaceutical Co., Ltd. | For profit | 3 | 3 | 1 | 2023 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 3 | 0 | 1 | 2023 |
| Melbourne Health | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of California, San Diego | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Zhejiang University | Academic/Hospital | 1 | 1 | 1 | 2025 |
7 organizations
Page 1 / 1